Research programme: apoptosis modulating compounds - Theraptosis

Drug Profile

Research programme: apoptosis modulating compounds - Theraptosis

Alternative Names: TRP 1; TRP 101; TRP 2; TRP 302; TRP 5; TRP 601; TRP 602; TRP 603; TRP 701; TRPXX

Latest Information Update: 06 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Theraptosis
  • Class
  • Mechanism of Action Apoptosis inhibitors; Apoptosis stimulants; Caspase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Chronic brain damage
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cancer; Chronic brain damage; Neurological disorders; Stroke

Most Recent Events

  • 21 Oct 2009 Pharmacodynamics data from preclinical trials in neonatal brain damage presented at the 39th Annual Meeting of the Society for Neuroscience (SfN-2009)
  • 06 Dec 2006 Preclinical trials in Cancer in France (unspecified route)
  • 06 Dec 2006 Preclinical trials in Neurological disorders in France (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top